When a Perfect Formula Meets the Realities of Commercial Manufacturing

Laboratory Success Is Only the First Step

Developing a natural health product is an exciting process, especially when a formulation performs exactly as intended during laboratory development. The powder blends uniformly, the suspension remains stable, the capsules fill consistently, and the finished product meets all the desired quality attributes. At this stage, it is easy to assume that increasing the batch size will produce the same outcome. In reality, scaling up a formulation is one of the most challenging stages of product development, and many promising formulations encounter unexpected obstacles once they move beyond the laboratory.

During bench scale development, formulators optimize several critical physical characteristics that influence both product quality and manufacturability. Properties such as particle size, viscosity, flowability, homogeneity, bulk density and moisture content are carefully evaluated because they determine how ingredients behave during mixing, filling, compression, or suspension. When these variables are properly balanced, the formulation often performs exceptionally well under controlled laboratory conditions. The question is whether those same conditions can be reproduced during commercial manufacturing.

Why Scaling Up Changes Everything

Although the formulation itself may remain unchanged, the manufacturing environment changes dramatically as production moves from the laboratory to commercial scale. Laboratory equipment and industrial equipment operate very differently. Larger vessels generate different mixing patterns, shear forces, energy input, heat transfer, and processing times, all of which influence how ingredients interact during production.

Consider particle size as an example. A fine and uniform particle size distribution may produce an excellent suspension or a free-flowing powder during laboratory trials. At commercial scale, however, the same material may segregate during transfer, generate excessive dust, or behave differently during blending because of changes in equipment design and material handling. Likewise, a viscosity that appears ideal when mixing a small laboratory batch may become difficult to manage in a large processing vessel where mixing efficiency and heat transfer are significantly different. Laboratory conditions cannot simply be multiplied to predict manufacturing performance because the physical forces acting on the product are no longer the same.

Understanding the Variables Beyond the Formulation

As production volumes increase, maintaining consistent product quality requires more than controlling the formulation itself. It also requires understanding how processing conditions influence the final product.

Homogeneity illustrates this challenge well. Uniform distribution of active ingredients is generally easier to achieve in a small laboratory batch because the mixing distances are short and material volumes are low. As batch size increases, maintaining the same level of uniformity depends on factors such as equipment geometry, mixing efficiency, material movement, and process control. Simply extending the mixing time does not always improve blend uniformity and, in some cases, excessive mixing can promote ingredient segregation.

The challenge becomes even greater when working with botanical ingredients. Unlike highly purified pharmaceutical compounds, botanical extracts naturally vary in particle shape, moisture content, oil content, density, and flow characteristics. Differences between suppliers, harvest seasons, or extraction methods can influence processing behaviour even when the botanical complies with its established specifications. These natural variations often require adjustments to manufacturing conditions without changing the formulation itself.

Building a Successful Scale Up Strategy

Successful scale up is therefore much more than increasing ingredient quantities. It requires identifying which material characteristics are critical to product quality while establishing manufacturing conditions that consistently reproduce those characteristics on commercial equipment.

Pilot scale production plays a vital role in this transition. It provides an opportunity to evaluate how the formulation responds under conditions that closely resemble full scale manufacturing and helps identify process parameters that may not have been evident during laboratory development. This approach allows formulators and manufacturing teams to refine mixing times, equipment settings, processing temperatures, and other operational parameters before commercial production begins.

From Formulation to Commercial Success

A successful laboratory formulation marks an important milestone, but it is only the beginning of the product development journey. The true measure of a well-designed natural health product is its ability to be manufactured efficiently and reproducibly at commercial scale.

Recognizing that laboratory measurements such as particle size, viscosity, flowability, and homogeneity are valuable indicators of formulation performance, rather than fixed manufacturing process parameters, enables formulators to make better scale up decisions. By combining sound formulation science with a thorough understanding of manufacturing processes, R&D specialists can reduce technical risks, improve technology transfer, and deliver high quality natural health products that perform reliably from the first laboratory batch to full commercial production.

References

1.      Aulton, M. E., & Taylor, K. M. G. (2022). Aulton's Pharmaceutics: The Design and Manufacture of Medicines (6th ed.). Elsevier.

2.      International Council for Harmonisation. (2009). ICH Q8(R2): Pharmaceutical Development.

3.      International Council for Harmonisation. (2023). ICH Q9(R1): Quality Risk Management.

4.      International Council for Harmonisation. (2008). ICH Q10: Pharmaceutical Quality System.

5.      Remington. (2020). Remington: The Science and Practice of Pharmacy (23rd ed.). Pharmaceutical Press.

6.      Parikh, D. M. (Ed.). (2021). Handbook of Pharmaceutical Granulation Technology (3rd ed.). CRC Press.